Podcasts Health & Fitness Medicine NEJM Interviews NEJM Interview: Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.

NEJM Interview: Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.

Published: Oct. 28, 2020, 3:01 p.m.

b'Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.L. Schwartz. Evaluating and Deploying Covid-19 Vaccines \\u2014 The Importance of Transparency, Scientific Integrity, and Public Trust. N Engl J Med 2020;383:1703-1705. M. Slaoui and M. Hepburn. Developing Safe and Effective Covid Vaccines \\u2014 Operation Warp Speed\\u2019s Strategy and Approach. N Engl J Med 2020;383:1701-1703. J. Avorn and A.S. Kesselheim. Up Is Down \\u2014 Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval. N Engl J Med 2020;383:1706-1708.'